Share on StockTwits

Shares of Genpact Limited (NYSE:G) have earned an average recommendation of “Hold” from the nine analysts that are presently covering the company, Stock Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $17.91.

Separately, analysts at Zacks upgraded shares of Genpact Limited from a “neutral” rating to an “outperform” rating in a research note on Tuesday. They now have a $19.40 price target on the stock.

Genpact Limited (NYSE:G) traded down 0.17% on Friday, hitting $17.33. 54,981 shares of the company’s stock traded hands. Genpact Limited has a 1-year low of $13.68 and a 1-year high of $20.36. The stock’s 50-day moving average is $17.70 and its 200-day moving average is $17.1. The company has a market cap of $3.749 billion and a price-to-earnings ratio of 18.65.

Genpact Limited (NYSE:G) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.27 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.26 by $0.01. The company had revenue of $561.60 million for the quarter, compared to the consensus estimate of $556.12 million. During the same quarter in the prior year, the company posted $0.32 earnings per share. The company’s quarterly revenue was up 5.0% on a year-over-year basis. On average, analysts predict that Genpact Limited will post $1.04 earnings per share for the current fiscal year.

Genpact Limited (NYSE:G), is engaged in business process management and information technology services, leveraging the power of processes, analytics and technology to help its clients drive intelligence across their enterprises.

Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.